These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 3454501
21. Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism. Nappi C, Farace MJ, Leone F, Minutolo M, Tommaselli AP, Montemagno U. Eur J Obstet Gynecol Reprod Biol; 1987 Jul; 25(3):209-19. PubMed ID: 2956138 [Abstract] [Full Text] [Related]
22. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations. Lello S, Primavera G, Colonna L, Vittori G, Guardianelli F, Sorge R, Raskovic D. Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543 [Abstract] [Full Text] [Related]
23. Pharmacodynamic studies on desogestrel administered alone and in combination with ethinylestradiol. Cullberg G. Acta Obstet Gynecol Scand Suppl; 1985 Dec; 133():1-30. PubMed ID: 3161265 [Abstract] [Full Text] [Related]
24. The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence. Venturoli S, Porcu E, Gammi L, Fabbri R, Paradisi R, Flamigni C, Patrono D, Capelli M, Paoletti C. Acta Eur Fertil; 1988 Dec; 19(3):129-34. PubMed ID: 2976224 [Abstract] [Full Text] [Related]
25. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel. Teichmann A. Int J Fertil Menopausal Stud; 1995 Dec; 40 Suppl 2():98-104. PubMed ID: 8574257 [Abstract] [Full Text] [Related]
26. Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome. Cullberg G, Hamberger L, Mattsson LA, Mobacken H, Samsioe G. Acta Obstet Gynecol Scand; 1985 Dec; 64(3):195-202. PubMed ID: 3160211 [Abstract] [Full Text] [Related]
27. Sex hormone-binding globulin as a marker of the effect of hormonal treatment in Turner's syndrome. Hampl R, Snajderova M, Lebl J, Lisa L, Dvorakova M, Hill M, Sulcova J, Starka L. Endocr Regul; 2001 Mar; 35(1):17-24. PubMed ID: 11308992 [Abstract] [Full Text] [Related]
28. Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome. De Leo V, Morgante G, Piomboni P, Musacchio MC, Petraglia F, Cianci A. Fertil Steril; 2007 Jul; 88(1):113-7. PubMed ID: 17418832 [Abstract] [Full Text] [Related]
29. Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial. Leelaphiwat S, Jongwutiwes T, Lertvikool S, Tabcharoen C, Sukprasert M, Rattanasiri S, Weerakiet S. J Obstet Gynaecol Res; 2015 Mar; 41(3):402-10. PubMed ID: 25319761 [Abstract] [Full Text] [Related]
30. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V. Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [Abstract] [Full Text] [Related]
31. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome. Falsetti L, Dordoni D, Gastaldi C, Gastaldi A. Acta Eur Fertil; 1986 Jan; 17(1):19-25. PubMed ID: 2941960 [Abstract] [Full Text] [Related]
32. Serum testosterone response to low dose dexamethasone and combined contraceptive pill in subgroups of patients with polycystic ovary syndrome. Prelević G, Würzburger M, Perić L. Acta Med Iugosl; 1989 Jan; 43(2):113-20. PubMed ID: 2741713 [Abstract] [Full Text] [Related]
33. Three triphasic oral contraceptives now available in U.S. Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912 [Abstract] [Full Text] [Related]
34. Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin. Song S, Chen JK, He ML, Fotherby K. Contraception; 1989 Apr; 39(4):385-99. PubMed ID: 2498034 [Abstract] [Full Text] [Related]
35. The effect of a low-dose oral contraceptive on serum testosterone levels in polycystic ovary disease. Talbert LM, Sloan C. Obstet Gynecol; 1979 Jun; 53(6):694-7. PubMed ID: 572024 [Abstract] [Full Text] [Related]
36. [Hypophyseal reaction state during oral contraceptiva (author's transl)]. Gitsch E, Schneider WH, Schmid R, Spona J. Wien Klin Wochenschr; 1981 Oct 16; 93(19):599-601. PubMed ID: 6798764 [Abstract] [Full Text] [Related]
37. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol. Akerlund M. Acta Obstet Gynecol Scand Suppl; 1997 Oct 16; 164():63-5. PubMed ID: 9225641 [Abstract] [Full Text] [Related]
38. [Pros and cons of triphasic oral contraception]. Berdah J. Contracept Fertil Sex (Paris); 1985 Dec 16; 13(12):1205-10. PubMed ID: 12267512 [Abstract] [Full Text] [Related]
39. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women. Frölich M, Lachinsky N, Moolenaar AJ. Acta Endocrinol (Copenh); 1977 Feb 16; 84(2):333-42. PubMed ID: 138326 [Abstract] [Full Text] [Related]
40. A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran. Kashanian M, Shahpourian F, Zare O. Eur J Obstet Gynecol Reprod Biol; 2010 May 16; 150(1):47-51. PubMed ID: 20185226 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]